⌘K
Loading ticker…
Boston Scientific Corp. · Healthcare · Medical Equipment
As of 2026-06-26, Boston Scientific Corp. (BSX) has a 3-month relative strength percentile of 8 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 33. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.0%, relative volume 1.34×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
8 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
BSX is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -16.7% / -44.4%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
BSX is held by 21 ETFs as of Mar 2026. Top owner: VTI at 0.15% weight, $3.0B notional. Top 3 carry $6.5B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.15% | $3.0B |
| VOOVanguard S&P 500 ETF | 0.17% | $2.4B |
| IVViShares Core S&P 500 ETF | 0.17% | $1.2B |
| SPYState Street SPDR S&P 500 ETF | 0.17% | $1.1B |
| VUGVanguard Growth ETF | 0.32% | $1.0B |
| XLVState Street Health Care Select Sector SPDR ETF | 1.75% | $677M |
| SPYMState Street SPDR Portfolio S&P 500 ETF | 0.17% | $196M |
| IWDiShares Russell 1000 Value ETF | 0.25% | $176M |
| MGKVanguard Mega Cap Growth ETF | 0.55% | $153M |
| IVWiShares S&P 500 Growth ETF | 0.22% | $131M |
Showing 10 of 21 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BSX Jan avg: 5.52% median: 4.69% win: 50% σ: 7.83% n: 4 2022-04-12 → 2026-05-29 | BSX Feb avg: -2.69% median: 1.21% win: 75% σ: 10.23% n: 4 2022-04-12 → 2026-05-29 | BSX Mar avg: -2.66% median: 0.32% win: 50% σ: 11.23% n: 4 2022-04-12 → 2026-05-29 | BSX Apr avg: -0.38% median: 1.97% win: 60% σ: 5.81% n: 5 2022-04-12 → 2026-05-29 | BSX May avg: -2.50% median: -1.23% win: 40% σ: 8.21% n: 5 2022-04-12 → 2026-05-29 | BSX Jun avg: -0.03% median: 1.97% win: 75% σ: 6.24% n: 4 2022-04-12 → 2026-05-29 (current) | BSX Jul avg: -0.10% median: -3.19% win: 25% σ: 6.88% n: 4 2022-04-12 → 2026-05-29 | BSX Aug avg: 3.37% median: 2.29% win: 75% σ: 5.45% n: 4 2022-04-12 → 2026-05-29 | BSX Sep avg: -2.76% median: -3.02% win: 25% σ: 4.13% n: 4 2022-04-12 → 2026-05-29 | BSX Oct avg: 2.92% median: 1.71% win: 75% σ: 6.14% n: 4 2022-04-12 → 2026-05-29 | BSX Nov avg: 5.74% median: 6.46% win: 100% σ: 3.69% n: 4 2022-04-12 → 2026-05-29 | BSX Dec avg: -0.49% median: 0.36% win: 50% σ: 4.30% n: 4 2022-04-12 → 2026-05-29 |